- TB remains a significant public health concern in Armenia, as the country has one of the highest rates of the multidrug-resistant (MDR-TB) form of the disease in the world.
- Since 2005, Médecins Sans Frontières has been working in Armenia to improve diagnosis and treatment of DR-TB, and to support patients to complete the arduous regimen.
- Between April 2013 and September 2014, Médecins Sans Frontières and the health ministry provided bedaquiline, a new drug developed in April 2013, to 46 patients. Médecins Sans Frontières supports the supply of the drug, as well as the day-to-day care and follow-up of patients taking it.
- Seasonal economic migration and the social stigma surrounding the disease further complicate the task of keeping patients under treatment.
- The team aims to enhance the national programme’s capacity to implement DR-TB response plans in preparation for the handover of DR-TB management, which should happen in 2016.
For the latest news about where we work visit: http://activityreport.msf.org/
Médecins Sans Frontières has been working in the country since 1988 and at the end of 2014, Médecins Sans Frontières had 91 staff in Armenia.